HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Pancreatic cancer is a formidable and often aggressive malignancy that originates in the tissues of the pancreas, an organ located behind the stomach. Unfortunately, pancreatic cancer is often diagnosed at an advanced stage, contributing to its reputation as one of the most challenging cancers to treat. Symptoms may be subtle or non-specific, leading to delayed detection. Common signs include abdominal pain, weight loss, jaundice, and digestive issues. Risk factors for pancreatic cancer include age, smoking, family history, and certain genetic mutations. The exact cause remains elusive, making prevention challenging. Diagnostic methods typically involve imaging tests, biopsies, and blood tests. Treatment options vary depending on the cancer's stage and extent. Surgical removal of the tumor, chemotherapy, and radiation therapy are commonly employed. However, due to the aggressive nature of pancreatic cancer, prognosis is often less favorable compared to some other cancers. Research and clinical trials continue to explore innovative treatments and early detection methods, offering hope for improved outcomes in the future. Patients and their families facing pancreatic cancer often navigate a complex journey, requiring a multidisciplinary approach involving medical professionals, support networks, and a focus on enhancing the quality of life during treatment.
